Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend. This story matters for Finance & Markets readers tracking largecap. Reported by marketwatch.com. Read the full original at the source link below.
Originally reported by marketwatch.com. LargecapNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily largecap signal